November/December 2024

View our interactive November/December 2024 digital edition.

Here, Brian C. Smith delves into the intricacies of the cradle-to-grave testing paradigm utilized in the pharmaceutical industry and how it could be adapted in the cannabis space.

Nanoemulsion technology is poised to play a pivotal role in the future of cannabinoid delivery as it helps address challenges related to the solubility, bioavailability, and stability of cannabinoids.

Robert Thomas investigates the costs that go into heavy metal testing through an informative exercise that debunks claims that a larger panel would significantly increase costs.

Advancements in blockchain technology point toward an evolving landscape where transparency, security protocols, and regulatory compliance integrate into standard cannabis operations.

Aspergillus, a genus of mold that is abundant in our environment, has become a significant concern in the cannabis industry, particularly due to the health risks it poses to consumers. This mold, which thrives in various environments, including soil, decaying vegetation, and even in the air, is not inherently dangerous to healthy individuals. However, its presence in cannabis flowers, whether during cultivation, processing, or storage, can lead to severe health risks, especially for immunocompromised individuals.